516 related articles for article (PubMed ID: 18992148)
21. Interleukin promoter polymorphisms and prognosis in colorectal cancer.
Wilkening S; Tavelin B; Canzian F; Enquist K; Palmqvist R; Altieri A; Hallmans G; Hemminki K; Lenner P; Försti A
Carcinogenesis; 2008 Jun; 29(6):1202-6. PubMed ID: 18448485
[TBL] [Abstract][Full Text] [Related]
22. Effect of COX2 -765G>C and c.3618A>G polymorphisms on the risk and survival of sporadic colorectal cancer.
Iglesias D; Nejda N; Azcoita MM; Schwartz S; González-Aguilera JJ; Fernández-Peralta AM
Cancer Causes Control; 2009 Oct; 20(8):1421-9. PubMed ID: 19468846
[TBL] [Abstract][Full Text] [Related]
23. DNA repair genetic polymorphisms and risk of colorectal cancer in the Czech Republic.
Pardini B; Naccarati A; Novotny J; Smerhovsky Z; Vodickova L; Polakova V; Hanova M; Slyskova J; Tulupova E; Kumar R; Bortlik M; Barale R; Hemminki K; Vodicka P
Mutat Res; 2008 Feb; 638(1-2):146-53. PubMed ID: 17991492
[TBL] [Abstract][Full Text] [Related]
24. Risk of genome-wide association study-identified genetic variants for colorectal cancer in a Chinese population.
Xiong F; Wu C; Bi X; Yu D; Huang L; Xu J; Zhang T; Zhai K; Chang J; Tan W; Cai J; Lin D
Cancer Epidemiol Biomarkers Prev; 2010 Jul; 19(7):1855-61. PubMed ID: 20530476
[TBL] [Abstract][Full Text] [Related]
25. Insulin pathway related genes and risk of colorectal cancer: INSR promoter polymorphism shows a protective effect.
Pechlivanis S; Pardini B; Bermejo JL; Wagner K; Naccarati A; Vodickova L; Novotny J; Hemminki K; Vodicka P; Försti A
Endocr Relat Cancer; 2007 Sep; 14(3):733-40. PubMed ID: 17914103
[TBL] [Abstract][Full Text] [Related]
26. PTPRJ haplotypes and colorectal cancer risk.
Toland AE; Rozek LS; Presswala S; Rennert G; Gruber SB
Cancer Epidemiol Biomarkers Prev; 2008 Oct; 17(10):2782-5. PubMed ID: 18843023
[TBL] [Abstract][Full Text] [Related]
27. MHC Class II alleles in ulcerative colitis-associated colorectal cancer.
Garrity-Park MM; Loftus EV; Sandborn WJ; Bryant SC; Smyrk TC
Gut; 2009 Sep; 58(9):1226-33. PubMed ID: 19251712
[TBL] [Abstract][Full Text] [Related]
28. [Association between genetic polymorphisms in folate metabolic enzyme genes and colorectal cancer: a nested case-control study].
Chen K; Song L; Jin MJ; Fan CH; Jiang QT; Yu WP
Zhonghua Zhong Liu Za Zhi; 2006 Jun; 28(6):429-32. PubMed ID: 17152488
[TBL] [Abstract][Full Text] [Related]
29. An update on the genetics of colorectal cancer.
Kemp Z; Thirlwell C; Sieber O; Silver A; Tomlinson I
Hum Mol Genet; 2004 Oct; 13 Spec No 2():R177-85. PubMed ID: 15358723
[TBL] [Abstract][Full Text] [Related]
30. Common germline MDR1/ABCB1 functional polymorphisms and haplotypes modify susceptibility to colorectal cancers with high microsatellite instability.
Potocnik U; Glavac D; Dean M
Cancer Genet Cytogenet; 2008 May; 183(1):28-34. PubMed ID: 18474294
[TBL] [Abstract][Full Text] [Related]
31. Combinations of cytochrome P450 gene polymorphisms enhancing the risk for sporadic colorectal cancer related to red meat consumption.
Küry S; Buecher B; Robiou-du-Pont S; Scoul C; Sébille V; Colman H; Le Houérou C; Le Neel T; Bourdon J; Faroux R; Ollivry J; Lafraise B; Chupin LD; Bézieau S
Cancer Epidemiol Biomarkers Prev; 2007 Jul; 16(7):1460-7. PubMed ID: 17627011
[TBL] [Abstract][Full Text] [Related]
32. Do polymorphisms and haplotypes of mismatch repair genes modulate risk of sporadic colorectal cancer?
Tulupova E; Kumar R; Hanova M; Slyskova J; Pardini B; Polakova V; Naccarati A; Vodickova L; Novotny J; Halamkova J; Hemminki K; Vodicka P
Mutat Res; 2008 Dec; 648(1-2):40-5. PubMed ID: 18851982
[TBL] [Abstract][Full Text] [Related]
33. Inflammation-related gene polymorphisms and colorectal adenoma.
Gunter MJ; Canzian F; Landi S; Chanock SJ; Sinha R; Rothman N
Cancer Epidemiol Biomarkers Prev; 2006 Jun; 15(6):1126-31. PubMed ID: 16775170
[TBL] [Abstract][Full Text] [Related]
34. Evaluating new candidate SNPs as low penetrance risk factors in sporadic breast cancer: a two-stage Spanish case-control study.
Vega A; Salas A; Milne RL; Carracedo B; Ribas G; Ruibal A; de León AC; González-Hernández A; Benítez J; Carracedo A
Gynecol Oncol; 2009 Jan; 112(1):210-4. PubMed ID: 18950845
[TBL] [Abstract][Full Text] [Related]
35. Polymorphisms within micro-RNA-binding sites and risk of sporadic colorectal cancer.
Landi D; Gemignani F; Naccarati A; Pardini B; Vodicka P; Vodickova L; Novotny J; Försti A; Hemminki K; Canzian F; Landi S
Carcinogenesis; 2008 Mar; 29(3):579-84. PubMed ID: 18192692
[TBL] [Abstract][Full Text] [Related]
36. Polymorphisms within inflammatory genes and colorectal cancer.
Landi S; Gemignani F; Bottari F; Gioia-Patricola L; Guino E; Cambray M; Biondo S; Capella G; Boldrini L; Canzian F; Moreno V
J Negat Results Biomed; 2006 Oct; 5():15. PubMed ID: 17062130
[TBL] [Abstract][Full Text] [Related]
37. Genetic analysis of caveolin-1 and eNOS genes in colorectal cancer.
Conde MC; Ramirez-Lorca R; Lopez-Jamar JM; Molero E; Ramírez-Armengol JA; Moreno Nogueira JA; Pascual MH; Ruiz A; Martín-Cordova CG; Real LM; Royo JL
Oncol Rep; 2006 Aug; 16(2):353-9. PubMed ID: 16820915
[TBL] [Abstract][Full Text] [Related]
38. Tumor necrosis factor-alpha polymorphisms in ulcerative colitis-associated colorectal cancer.
Garrity-Park MM; Loftus EV; Bryant SC; Sandborn WJ; Smyrk TC
Am J Gastroenterol; 2008 Feb; 103(2):407-15. PubMed ID: 18289203
[TBL] [Abstract][Full Text] [Related]
39. No association between genetic polymorphisms in NAD(P)H oxidase p22phox and paraoxonase 1 and colorectal cancer risk.
Van Der Logt EM; Janssen CH; Van Hooijdonk Z; Roelofs HM; Wobbes T; Nagengast FM; Peters WH
Anticancer Res; 2005; 25(2B):1465-70. PubMed ID: 15865106
[TBL] [Abstract][Full Text] [Related]
40. Single nucleotide polymorphisms in the hypoxia-inducible factor-1 gene and colorectal cancer risk.
Knechtel G; Szkandera J; Stotz M; Hofmann G; Langsenlehner U; Krippl P; Samonigg H; Renner W; Langner C; Dehchamani D; Gerger A
Mol Carcinog; 2010 Sep; 49(9):805-9. PubMed ID: 20572162
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
